We found that PSD could only effectively inhibit cell proliferation in RAC3 overexpressing cells, indicating that PSD enhances the sensitivity of lung cancer cells to paclitaxel by inhibiting RAC3 expression. This evidence concerns the gene RAC3 and lung carcinoma.